Mercados españoles cerrados

Hypera S.A. (HYPE3.SA)

São Paulo - São Paulo Precio demorado. Divisa en BRL
Añadir a la lista de favoritos
30,26+0,47 (+1,58%)
Al cierre: 05:07PM BRT

Hypera S.A.

Av. Magalhães de Castro, 4800
240 Floor Continental Tower Building Bairro Cidade Jardim
São Paulo, SP 05676-120
Brazil
55 11 3627 4206
https://www.hyperapharma.com.br

Sector(es)Healthcare
SectorDrug Manufacturers - Specialty & Generic
Empleados a tiempo completo10.301

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Breno Toledo Pires de OliveiraCEO & DirectorN/AN/AN/A
Mr. Adalmario Ghovatto Satheler do CoutoInvestor Relations Officer & CFON/AN/AN/A
Mr. Carlos Roberto ScorsiChief Operating officerN/AN/A1962
Juliana Aguinaga Damião SalemSenior Legal Officer & DirectorN/AN/AN/A
Joao Felipe Khamis AguilarRisks & Compliance OfficerN/AN/AN/A
Mr. Luiz Eduardo Sales ClavisVP of Sales and Marketing & DirectorN/AN/AN/A
Mauricio ChristovamSenior Human Resources OfficerN/AN/AN/A
Mr. Hélio SegourasHead of Consumer HealthN/AN/AN/A
Los importes son a partir de y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en BRL.

Descripción

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, balance, Flavonid, histamin, NeoFresh, neolefrin, Neochemistry Vitamins, Neosorum, and Torsilax brand names; and consumer health products under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.

Gobierno corporativo

El ISS Governance QualityScore de Hypera S.A., a día 1 de mayo de 2024, es 6. Las puntuaciones base son Auditoría: 3; Tablero: 7; Derechos de los accionistas: 1; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.